Lumenis

Lumenis is a global leader in medical and aesthetic lasers, as well as energy-based technology. The company creates and manufactures a variety of cutting-edge products and solutions for surgical, ophthalmic, aesthetic, and veterinary purposes. Lumenis was founded in 1966 and is headquartered in Yokneam, Israel, with operations in over 100 locations worldwide.

The UltraPulse CO2 laser, the LightSheer diode laser for hair removal, and the M22 IPL platform for skin rejuvenation and vascular lesions are among their most well-known products.

Indeed, the business is credited with developing the first CO2 surgical laser more than 50 years ago. Lumenis has continued to create new technologies and products to satisfy the changing demands of healthcare practitioners and patients since then.

Today, the company provides a diverse range of medical and aesthetic products and solutions. Laser systems for surgical and ophthalmic operations, as well as energy-based devices for non-invasive aesthetic treatments including hair removal, skin rejuvenation, and body contouring, are examples of these. Lumenis also offers training and assistance to help healthcare providers get the most out of their devices.

Lumenis has a presence in the veterinary sector in addition to its medical and aesthetic businesses. The company provides a variety of laser and energy-based animal healthcare treatments, including surgical and dental procedures.

Lumenis announced revenue of roughly $351 million for the fiscal year 2023. Lumenis is a global leader in the medical and aesthetic laser markets, with a solid reputation for innovation, quality, and customer service.

Founded: 1966
Headquarters: 6 Hakidma, Yokneam, North District, 2069204, Israel
Website: https://lumenis.com/